02882oam 2200697I 450 991082258490332120230803025728.01-04-006064-10-429-10783-81-4398-5564-110.1201/b13876 (CKB)2670000000341435(EBL)1142012(OCoLC)830162620(SSID)ssj0000832668(PQKBManifestationID)11501379(PQKBTitleCode)TC0000832668(PQKBWorkID)10899397(PQKB)10258981(Au-PeEL)EBL1142012(CaPaEBR)ebr10666210(OCoLC)834627939(MiAaPQ)EBC1142012(OCoLC)1280141418(FINmELB)ELB141048(EXLCZ)99267000000034143520180331d2013 uy 0engur|n|---|||||txtccrApplying genomic and proteomic microarray technology in drug discovery /Robert S. Matson2nd ed.Boca Raton Taylor & Francis2013Boca Raton :Taylor & Francis,2013.1 online resource (313 p.)Description based upon print version of record.1-4398-5563-3 Includes bibliographical references.Omics & microarrays revisited -- The commercial microarray -- Supports & surface chemistries -- The arraying process -- Gene expression microarray-based applications -- Protein microarray applications -- Multiplex assays.Microarrays play an increasingly significant role in drug discovery. The commercial landscape has changed dramatically over the past few years and researchers have made great advancements with regard to construction and use. Now in its second edition, Applying Genomic and Proteomic Microarray Technology in Drug Discovery highlights, describes, and evaluates current scientific research using microarray technology in genomic and proteomic applications.Updated and revised to reflect recent progress in the field, the second edition discusses: Expanded omics-driven applications, including the areasHigh throughput screening (Drug development)DNA microarraysProtein microarraysPharmacogenomicsProteomicsHigh throughput screening (Drug development)DNA microarrays.Protein microarrays.Pharmacogenomics.Proteomics.615.1/9Matson Robert S.1637811MiAaPQMiAaPQMiAaPQBOOK9910822584903321Applying genomic and proteomic microarray technology in drug discovery3979844UNINA